Pharmabiz

IIT Bombay’s TIH concludes ATMAN 3.0; 6 HealthTech startups to get upto Rs. 6 crore cumulative seed funding

Our Bureau, Bengaluru Monday, January 12, 2026, 17:30 Hrs [IST] ...
Pharmabiz

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics: Redwood City, California Mon ...
Pharmabiz

Phanes Therapeutics reports positive phase 2 results of spevatamig in combo with chemotherapy in frontline treatment of metastatic PDAC

Phanes Therapeutics reports positive phase 2 results of spevatamig in combo with chemotherapy in frontline treatment of metastatic PDAC: San Diego Monday, January 12, 2026, 18:00 ...
Pharmabiz

Avista Therapeutics expands AI gene therapy platform to break barriers in the delivery of genetic medicines

Avista Therapeutics expands AI gene therapy platform to break barriers in the delivery of genetic medicines: Pittsburgh Monday, January 12, 2026, 16:00 Hrs [IST] Avista Therapeuti ...
Pharmabiz

Jubilant Biosys doubles early chemistry scale-up capacity with new Noida facility in India

Jubilant Biosys doubles early chemistry scale-up capacity with new Noida facility in India: Our Bureau, Bengaluru Monday, January 12, 2026, 17:15 Hrs [IST] Jubilant Biosys, a whol ...
Pharmabiz

Bio Asia 23rd edition 2026 from Feb 17-18, 2026 themed as TechBio unleashed: AI, automation & the biology revolution

Bio Asia 23rd edition 2026 from Feb 17-18, 2026 themed as TechBio unleashed: AI, automation & the biology revolution: Our Bureau, Bengaluru Monday, January 12, 2026, 09:00 Hrs [IS ...
Pharmabiz

Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months

Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months: Our Bureau, Bengaluru Monday, January 12, 2026, 14:15 Hrs [IST] Aragen launche ...
Pharmabiz

Cycle Pharma and Inceptua expand Free Goods Programme for patients with hereditary tyrosinemia type 1 and Alkaptonuria to Include Morocco & Egypt

Cycle Pharma and Inceptua expand Free Goods Programme for patients with hereditary tyrosinemia type 1 and Alkaptonuria to Include Morocco & Egypt: Windsor, London Monday, January ...
Pharmabiz

GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder

GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...
Pharmabiz

Alembic Pharmaceuticals receives US FDA tentative approval for Bosutinib tablets

Alembic Pharmaceuticals receives US FDA tentative approval for Bosutinib tablets: Our Bureau, Mumbai Monday, January 12, 2026, 14:30 Hrs [IST] Alembic Pharmaceuticals Limited (Ale ...
Pharmabiz

Nona Biosciences inks agreement with Link Cell Therapies to advance CAR-T cell therapies

Nona Biosciences inks agreement with Link Cell Therapies to advance CAR-T cell therapies: Cambridge, Massachusetts Monday, January 12, 2026, 11:00 Hrs [IST] Nona Biosciences (Nona ...
Pharmabiz

Novartis to build its fourth US radioligand therapy manufacturing facility in Winter Park, Florida with an investment of $23 billion

Novartis to build its fourth US radioligand therapy manufacturing facility in Winter Park, Florida with an investment of $23 billion: Basel Monday, January 12, 2026, 10:00 Hrs [IS ...